Roopa Industries Ltd

ROOPAIND

Watchlist

AI Mode

‌

Market Cap

₹ 39 Cr

P/E

20.25

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

HIGH RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Roopa Industries Limited, part of the TGV Group, is a manufacturer and exporter of Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids, and Water Treatment Chemicals, with operations since 1985.

The company transitioned into producing Neutraceuticals, Fine chemicals, Drug Intermediates, and Bulk Drugs in 1998, serving a wide range of international clients.

Roopa Industries specializes in hazardous and intricate manufacturing processes, particularly known for its technical expertise in organic synthesis applications.

Key products include Active Pharmaceutical Ingredients like Fluconazole, Sildenafil Citrate, and several nutraceuticals such as Glucosamine salts, known for their therapeutic benefits in managing arthritis.

Their major export markets include Germany, the Netherlands, and Sri Lanka, which underscores their global market penetration.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

39 Cr

Volatility

Low Risk

P/E Ratio

20.3

Industry P/E

59.1

PEG Ratio

0.8

P/B Ratio

2.1

52W High

86.34

52W Low

41.34

Sales CAGR

71.36%

33.08%

34.28%

10Y

15.38%

Profit CAGR

33.55%

26.09%

40.47%

10Y

31.64%

ROE

TTM

10.56%

10.45%

9.34%

10Y

7.07%

ROCE

TTM

10.48%

21.35%

17.77%

10Y

14.15%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GODAVARI	74.30	56 Cr	12.80	1.29	0.00	8.16	7.47	2.28
BACPHAR	37.01	53 Cr	84.11	1.99	0.00	2.42	3.29	2.41
ROOPAIND	49.62	39 Cr	20.25	2.14	0.00	10.56	10.48	2.22
VILINBIO	18.95	26 Cr	118.44	1.15	0.00	1.08	3.59	1.00
ISHITADR	74.10	22 Cr	22.35	1.93	0.00	8.65	10.56	6.66
CHEMOPH	123.60	19 Cr	—	12.90	0.00	-850.15	-830.59	-593.20
VENMAX	28.44	15 Cr	43.09	2.57	0.00	4.02	3.11	2.49

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	15	14	19	22	35	26	31	30	35	29
Expenses	14	12	18	21	33	24	30	29	34	27
Operating Profit	1.04	1.70	0.89	0.92	1.05	1.64	0.97	0.44	1.40	1.63
OPM %	6.96	12.01	4.63	4.17	3.04	6.40	3.16	1.48	3.99	5.67
Other Income	0.00	0.02	0.40	0.71	0.24	0.00	0.92	1.14	0.02	0.00
Interest	0.56	0.69	0.70	0.68	0.79	0.71	0.67	0.66	0.86	0.83
Depreciation	0.23	0.23	0.23	0.19	0.20	0.20	0.26	0.19	0.20	0.19
Profit Before Tax	0.25	0.80	0.36	0.76	0.30	0.73	0.96	0.74	0.37	0.62
Tax %	24.00	25.00	25.00	40.79	10.00	19.18	20.83	43.24	21.62	24.19
Net Profit	0.19	0.60	0.27	0.46	0.27	0.58	0.76	0.42	0.28	0.46
EPS in Rs	0.25	0.77	0.34	0.59	0.35	0.74	0.97	0.51	0.36	0.59

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	33	20	30	28	29	51	76	70	121	121
Expenses	28	22	28	26	26	48	72	66	117	117
Operating Profit	5.08	-2.02	2.47	1.78	2.72	3.44	3.89	4.44	4.11	4.45
OPM %	15.49	-10.36	8.18	6.45	9.49	6.71	5.10	6.31	3.41	3.67
Other Income	0.22	4.65	0.28	1.09	0.08	0.06	0.65	1.13	2.30	NaN
Interest	1.52	1.05	1.39	1.31	1.05	1.21	1.84	2.52	2.83	2.90
Depreciation	0.51	0.52	0.57	0.76	0.81	0.93	0.89	0.87	0.85	0.85
Profit Before Tax	0.43	0.44	0.79	0.80	0.93	1.36	1.81	2.17	2.72	2.80
Tax %	55.92	-22.32	23.49	53.50	23.20	25.38	25.31	30.12	25.23	27.14
Net Profit	0.19	0.54	0.60	0.37	0.72	1.02	1.35	1.52	2.03	2.04
EPS in Rs	0.86	0.58	0.77	0.49	1.01	1.32	1.73	1.95	2.57	2.43
Dividend Payout %	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.87	7.87	7.87	7.87	7.87	7.87	7.87	7.87	7.87	7.87
Reserves	0.96	1.50	1.95	2.56	2.93	3.70	4.72	6.08	7.61	9.63
Borrowings	7.73	11	15	13	12	12	12	19	26	33
Other Liabilities	8.71	8.93	11	13	15	22	24	24	23	26
Total Liabilities	25	29	35	36	38	46	49	57	65	76
Fixed Assets	6.91	6.76	6.29	6.30	11	10	9.69	9.98	8.74	7.93
CWIP	0.02	0.03	2.39	4.49	0.00	0.10	0.69	0.88	0.88	0.88
Investments	0.04	0.16	0.02	0.01	0.01	0.01	0.01	0.01	0.02	0.02
Other Assets	18	22	27	26	28	36	39	46	55	68
Total Assets	25	29	35	36	38	46	49	57	65	76

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	1.27	-1.17	-4.53	4.42	2.44	-0.52	2.34	-0.37	-3.28	-6.59
Cash from Investing Activity	0.19	-0.45	2.50	-2.43	0.70	1.34	3.65	-0.99	1.11	2.18
Cash from Financing Activity	-1.49	1.56	2.05	-1.88	-3.06	-0.58	-5.01	1.81	3.20	4.82
Net Cash Flow	-0.02	-0.07	0.02	0.11	0.08	0.25	0.99	0.45	1.03	0.40

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	48.03%	48.03%	48.03%	48.03%	48.03%	48.03%	48.03%	48.03%	48.03%	48.03%	48.03%	48.03%
FIIs	0.25%	0.25%	0.25%	0.25%	0.25%	0.25%	0.25%	0.25%	0.25%	0.25%	0.25%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.26%
Public	51.72%	51.72%	51.72%	51.72%	51.72%	51.72%	51.72%	51.72%	51.71%	51.71%	51.71%	51.71%
Total Shareholders	3,505	3,455	3,513	3,490	3,584	3,622	3,616	3,813	4,005	4,007	4,002	3,982

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Regulatory Filing

4 days ago

Re-Lodgement of Transfer Requests Update

Report submitted on the re-lodgement of transfer requests for physical shares under the special window as per SEBI guidelines.

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	15	14	19	22	35	26	31	30	35	29
Expenses	14	12	18	21	33	24	30	29	34	27
Operating Profit	1.04	1.70	0.89	0.92	1.05	1.64	0.97	0.44	1.40	1.63
OPM %	6.96	12.01	4.63	4.17	3.04	6.40	3.16	1.48	3.99	5.67
Other Income	0.00	0.02	0.40	0.71	0.24	0.00	0.92	1.14	0.02	0.00
Interest	0.56	0.69	0.70	0.68	0.79	0.71	0.67	0.66	0.86	0.83
Depreciation	0.23	0.23	0.23	0.19	0.20	0.20	0.26	0.19	0.20	0.19
Profit Before Tax	0.25	0.80	0.36	0.76	0.30	0.73	0.96	0.74	0.37	0.62
Tax %	24.00	25.00	25.00	40.79	10.00	19.18	20.83	43.24	21.62	24.19
Net Profit	0.19	0.60	0.27	0.46	0.27	0.58	0.76	0.42	0.28	0.46
EPS in Rs	0.25	0.77	0.34	0.59	0.35	0.74	0.97	0.51	0.36	0.59

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	33	20	30	28	29	51	76	70	121	121
Expenses	28	22	28	26	26	48	72	66	117	117
Operating Profit	5.08	-2.02	2.47	1.78	2.72	3.44	3.89	4.44	4.11	4.45
OPM %	15.49	-10.36	8.18	6.45	9.49	6.71	5.10	6.31	3.41	3.67
Other Income	0.22	4.65	0.28	1.09	0.08	0.06	0.65	1.13	2.30	NaN
Interest	1.52	1.05	1.39	1.31	1.05	1.21	1.84	2.52	2.83	2.90
Depreciation	0.51	0.52	0.57	0.76	0.81	0.93	0.89	0.87	0.85	0.85
Profit Before Tax	0.43	0.44	0.79	0.80	0.93	1.36	1.81	2.17	2.72	2.80
Tax %	55.92	-22.32	23.49	53.50	23.20	25.38	25.31	30.12	25.23	27.14
Net Profit	0.19	0.54	0.60	0.37	0.72	1.02	1.35	1.52	2.03	2.04
EPS in Rs	0.86	0.58	0.77	0.49	1.01	1.32	1.73	1.95	2.57	2.43
Dividend Payout %	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.87	7.87	7.87	7.87	7.87	7.87	7.87	7.87	7.87	7.87
Reserves	0.96	1.50	1.95	2.56	2.93	3.70	4.72	6.08	7.61	9.63
Borrowings	7.73	11	15	13	12	12	12	19	26	33
Other Liabilities	8.71	8.93	11	13	15	22	24	24	23	26
Total Liabilities	25	29	35	36	38	46	49	57	65	76
Fixed Assets	6.91	6.76	6.29	6.30	11	10	9.69	9.98	8.74	7.93
CWIP	0.02	0.03	2.39	4.49	0.00	0.10	0.69	0.88	0.88	0.88
Investments	0.04	0.16	0.02	0.01	0.01	0.01	0.01	0.01	0.02	0.02
Other Assets	18	22	27	26	28	36	39	46	55	68
Total Assets	25	29	35	36	38	46	49	57	65	76

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	1.27	-1.17	-4.53	4.42	2.44	-0.52	2.34	-0.37	-3.28	-6.59
Cash from Investing Activity	0.19	-0.45	2.50	-2.43	0.70	1.34	3.65	-0.99	1.11	2.18
Cash from Financing Activity	-1.49	1.56	2.05	-1.88	-3.06	-0.58	-5.01	1.81	3.20	4.82
Net Cash Flow	-0.02	-0.07	0.02	0.11	0.08	0.25	0.99	0.45	1.03	0.40

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Overview

Detailed Summary

The company transitioned into producing Neutraceuticals, Fine chemicals, Drug Intermediates, and Bulk Drugs in 1998, serving a wide range of international clients.

Roopa Industries specializes in hazardous and intricate manufacturing processes, particularly known for its technical expertise in organic synthesis applications.

Their major export markets include Germany, the Netherlands, and Sri Lanka, which underscores their global market penetration.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

39 Cr

Volatility

Low Risk

P/E Ratio

20.3

Industry P/E

59.1

PEG Ratio

0.8

P/B Ratio

2.1

52W High

86.34

52W Low

41.34

Sales CAGR

71.36%

33.08%

34.28%

10Y

15.38%

Profit CAGR

33.55%

26.09%

40.47%

10Y

31.64%

ROE

TTM

10.56%

10.45%

9.34%

10Y

7.07%

ROCE

TTM

10.48%

21.35%

17.77%

10Y

14.15%

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GODAVARI	74.30	56 Cr	12.80	1.29	0.00	8.16	7.47	2.28
BACPHAR	37.01	53 Cr	84.11	1.99	0.00	2.42	3.29	2.41
ROOPAIND	49.62	39 Cr	20.25	2.14	0.00	10.56	10.48	2.22
VILINBIO	18.95	26 Cr	118.44	1.15	0.00	1.08	3.59	1.00
ISHITADR	74.10	22 Cr	22.35	1.93	0.00	8.65	10.56	6.66
CHEMOPH	123.60	19 Cr	—	12.90	0.00	-850.15	-830.59	-593.20
VENMAX	28.44	15 Cr	43.09	2.57	0.00	4.02	3.11	2.49